Literature DB >> 7794918

Binding of vinblastine to phosphocellulose-purified and alpha beta-class III tubulin: the role of nucleotides and beta-tubulin isotypes.

S Lobert1, A Frankfurter, J J Correia.   

Abstract

Vinblastine is an antimitotic drug that inhibits microtubule assembly and induces the self-association of tubulin into coiled spiral aggregates. Previous quantitative binding and sedimentation velocity results have been interpreted by a mechanism involving isodesmic ligand-mediated plus ligand-facilitated self-association [Na, G., & Timasheff, S. N. (1986) Biochemistry 25, 6214-6222, 6222-6228]. In this study, the vinblastine-induced self-association of porcine brain tubulin has been compared in the presence of 50 microM GDP or 50 microM GTP to investigate the role of nucleotides. Experiments at 1-4 microM tubulin in 10 mM Pipes, 1 mM MgSO4, 2 mM EGTA (pH 6.9), and varying concentrations of vinblastine (0.05-70 microM) demonstrate that GDP enhances self-association by 2-4-fold over GTP. In the presence of GDP or GTP, sedimentation velocity data can be best fit by either an indefinite ligand-mediated model or an indefinite ligand-mediated plus ligand-facilitated model. The association constant, K2, for the vinblastine-tubulin complex binding to a polymer is larger when GDP is present, while the association constant, K1, for the binding of vinblastine to tubulin heterodimers is identical in the presence of either nucleotide. The enhancement of K2 by GDP is confirmed by micropartition binding experiments with [3H]vinblastine. The fitting of sedimentation velocity and binding studies gives parameters for the interaction of vinblastine with GTP-tubulin that are identical, within error, to the previous results of Na and Timasheff. van't Hoff analysis of multiple temperature data reveals that this enhancement in the presence of GDP is due to a change in the enthalpy of self-association. Additional results suggest that the interaction of vinblastine with tubulin is identical for all beta-isotypes. Sedimentation velocity experiments in the presence of GDP or GTP show that the vinblastine-induced association of affinity-purified alpha,beta-class III tubulin is identical to that of unfractionated tubulin, although there is a difference in the abilities of unfractionated tubulin and alpha,beta III-tubulin to associate into taxol-stabilized microtubules.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7794918     DOI: 10.1021/bi00025a011

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Divalent cation and ionic strength effects on Vinca alkaloid-induced tubulin self-association.

Authors:  S Lobert; C A Boyd; J J Correia
Journal:  Biophys J       Date:  1997-01       Impact factor: 4.033

2.  Different effects of vinblastine on the polymerization of isotypically purified tubulins from bovine brain.

Authors:  Israr A Khan; Richard F Ludueña
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

3.  A novel use of gentamicin in the ROS-mediated sensitization of NCI-H460 lung cancer cells to various anticancer agents.

Authors:  Michael F Cuccarese; Amit Singh; Mansoor Amiji; George A O'Doherty
Journal:  ACS Chem Biol       Date:  2013-10-17       Impact factor: 5.100

4.  Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine.

Authors:  Ashish Aggarwal; Anna Kruczynski; Anthony Frankfurter; John J Correia; Sharon Lobert
Journal:  Invest New Drugs       Date:  2007-12-11       Impact factor: 3.850

5.  Ansamitocin P3 depolymerizes microtubules and induces apoptosis by binding to tubulin at the vinblastine site.

Authors:  Jubina B Venghateri; Tilak Kumar Gupta; Paul J Verma; Ambarish Kunwar; Dulal Panda
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

6.  Beta class II tubulin predominates in normal and tumor breast tissues.

Authors:  James H Dozier; Laree Hiser; Jennifer A Davis; Nancy Stubbs Thomas; Michelle A Tucci; Hamed A Benghuzzi; Anthony Frankfurter; John J Correia; Sharon Lobert
Journal:  Breast Cancer Res       Date:  2003-07-28       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.